Han J - Search Results

1

COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma.

Sternberg CN, Motzer RJ, Hutson TE, Choueiri TK, Kollmannsberger C, Bjarnason GA, Paul Nathan, Porta C, Grünwald V, Dezzani L, Han J, Tannir NM. Sternberg CN, et al. Among authors: han j. Clin Genitourin Cancer. 2019 Dec;17(6):425-435.e4. doi: 10.1016/j.clgc.2019.01.015. Epub 2019 Feb 6. Clin Genitourin Cancer. 2019. PMID: 31601514 Free PMC article. Clinical Trial.

2

Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial.

Guo J, Jin J, Oya M, Uemura H, Takahashi S, Tatsugami K, Rha SY, Lee JL, Chung J, Lim HY, Wu HC, Chang YH, Azad A, Davis ID, Carrasco-Alfonso MJ, Nanua B, Han J, Ahmad Q, Motzer R. Guo J, et al. Among authors: han j. J Hematol Oncol. 2018 May 22;11(1):69. doi: 10.1186/s13045-018-0617-1. J Hematol Oncol. 2018. PMID: 29788981 Free PMC article. Clinical Trial.

3

Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials.

Koenig W, Conde LG, Landmesser U, Leiter LA, Ray KK, Schwartz GG, Wright RS, Han J, Raal FJ. Koenig W, et al. Among authors: han j. Cardiovasc Drugs Ther. 2024 Jun;38(3):493-503. doi: 10.1007/s10557-022-07413-0. Epub 2022 Dec 23. Cardiovasc Drugs Ther. 2024. PMID: 36550348 Free PMC article. Clinical Trial.

4

Cardiovascular Outcomes in De Novo Kidney Transplant Recipients Receiving Everolimus and Reduced Calcineurin Inhibitor or Standard Triple Therapy: 24-month Post Hoc Analysis From TRANSFORM Study.

Sommerer C, Legendre C, Citterio F, Watarai Y, Oberbauer R, Basic-Jukic N, Han J, Gawai A, Bernhardt P, Chadban S. Sommerer C, et al. Among authors: han j. Transplantation. 2023 Jul 1;107(7):1593-1604. doi: 10.1097/TP.0000000000004555. Epub 2023 Jun 20. Transplantation. 2023. PMID: 36959121

5

BGG492 as an adjunctive treatment in patients with partial-onset seizures: A 12-week, randomized, double-blind, placebo-controlled, phase II dose-titration study with an open-label extension.

Elger CE, Hong SB, Brandt C, Mancione L, Han J, Strohmaier C. Elger CE, et al. Among authors: han j. Epilepsia. 2017 Jul;58(7):1217-1226. doi: 10.1111/epi.13771. Epub 2017 May 13. Epilepsia. 2017. PMID: 28500678 Clinical Trial.

6

Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis.

Taher AT, Origa R, Perrotta S, Kouraklis A, Belhoul K, Huang V, Han J, Bruederle A, Bobbili P, Duh MS, Porter JB. Taher AT, et al. Among authors: han j. Am J Hematol. 2019 Apr;94(4):E96-E99. doi: 10.1002/ajh.25408. Epub 2019 Jan 31. Am J Hematol. 2019. PMID: 30663129 Free PMC article. Clinical Trial. No abstract available.

7

Inclisiran in patients with prior myocardial infarction: A post hoc pooled analysis of the ORION-10 and ORION-11 Phase 3 randomised trials.

Landmesser U, Koenig W, Leiter LA, Raal FJ, Ray KK, Wright RS, Han J, Conde LG, Schwartz GG. Landmesser U, et al. Among authors: han j. Atherosclerosis. 2023 Dec;386:117354. doi: 10.1016/j.atherosclerosis.2023.117354. Epub 2023 Oct 18. Atherosclerosis. 2023. PMID: 38016401 Free article. Clinical Trial.

8

Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION-9, ORION-10 and ORION-11 Phase 3 randomized trials.

Leiter LA, Raal FJ, Schwartz GG, Koenig W, Ray KK, Landmesser U, Han J, Conde LG, Wright RS. Leiter LA, et al. Among authors: han j. Diabetes Obes Metab. 2024 May 17. doi: 10.1111/dom.15650. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38757725

9

A pre-specified statistical analysis plan for the VERIFY study: Vildagliptin efficacy in combination with metformin for early treatment of T2DM.

Matthews DR, Paldánius PM, Stumvoll M, Han J, Bader G, Chiang Y, Proot P, Del Prato S. Matthews DR, et al. Among authors: han j. Diabetes Obes Metab. 2019 Oct;21(10):2240-2247. doi: 10.1111/dom.13800. Epub 2019 Jun 30. Diabetes Obes Metab. 2019. PMID: 31144427 Free PMC article. Clinical Trial.

10

Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia.

Porter JB, Elalfy M, Taher A, Aydinok Y, Lee SH, Sutcharitchan P, El-Ali A, Han J, El-Beshlawy A. Porter JB, et al. Among authors: han j. Eur J Haematol. 2017 Mar;98(3):280-288. doi: 10.1111/ejh.12830. Epub 2017 Jan 13. Eur J Haematol. 2017. PMID: 27859648 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30,468 results

Search Page